News & Events

Investor Center

Careers

Pipeline

Partnership

About  Us

About Us

Research & Development

Research & Development Pipeline Partership Investor Center News & Events Careers
Home

中文

Contact
   Home    Home-Ch
Press Releases
More Ascletis News
News & Events
© 2016 Ascletis. All Rights Reserved
浙公网安备 33010802003344 号
CONTACT US
pr@ascletis.com
hr@ascletis.com
bd@ascletis.com
clinicaltrials@ascletis.com
Contact

Dec 28, 2017   Ascletis was Accredited as a National High-Tech Enterprise  >>

Jan 05, 2018   The Wall Street Journal: Populations of Data Propel China to the Forefront of Biotech >>

20180105TheWallStreet.pdf

Jan 10, 2018   Ascletis  Presented at 2018 J.P.Morgan Healthcare Conference >>

20180110JPMorgan.pdf

Aug 20, 2017   Zhejiang Initiated Eliminate Hepatitis C Program >>

20170820Xinhua.pdf

Sep 19, 2017   Ascletis Won the First Prize in the China Innovation and Entrepreneurship Competition at Healthcare Sector Final  >>

20170919FirstPrize.pdf

Jan 11, 2018   South China Morning Post: Chinese Biotech Company Ascletis Seeks 3rd Round of Funding that Exceed US$100M  >>

20171228NationalHiTech.pdf 20180111SouthChinaMorningPost.pdf
CCTV Report on HCV
Partnership
IHEPA Interview
20170818Medivir.pdf XinyueChen.pdf

Guidelines for the HCV Treatment

GuidelinesForHCV2015.pdf
HIV in China
Video
Corporate Member

Ascletis is a specialty therapeutics company dedicated to discovering

and developing important new treatments for cancer and infectious diseases.

HCV IN CHINA

歌礼与您携手

共同抗击肝炎

Together, Cure Hepatitis

7.28 世界肝炎日

World Hepatitis Day